China growth and global non-US Internet equities

Blue Lotus Research Institute

Blue Lotus Research is a Hong Kong Type 4 Licensed investment advisory firm focusing on Chinese growth equities and global non-US Internet equities

[Weibo (WB US) Target Price Change]: Rebound After Temporary Disturbance, Maintain BUY

[Weibo (WB US) Earnings Review]: Maintain BUY for Ads Recovery in Coming Quarters

Weibo (WB US) – Recovery on the horizon despite ST pressure

China/Asia TMT

Shawn Yang

Equity Bottom-Up

<ul>
<li>Weibo’s 1Q23 top line was in line with our est., and non-GAAP net income beat our est./cons. by 6.5%/ 7.6%, due to cost-saving measures. </li>
<li>While we dial down its 2Q23 revenue forecast, we remain optimistic about its growth in 2H23, as more brand advertisers gradually recover. </li>
<li>Maintain BUY and TP unchanged, which implies 12X PE in 2023.</li>
</ul>


Weibo’s 1Q23 top line was in line with our est., and non-GAAP net income beat our est./cons. by 6.5%/ 7.6%, due to cost-saving measures. 
While we dial down its 2Q23 revenue forecast, we remain optimistic about its growth in 2H23, as more brand advertisers gradually recover. 
Maintain BUY and TP unchanged, which implies 12X PE in 2023.


Weibo (WB US, BUY, TP US$26.9) Earnings Review: Maintain BUY for Margin Improvement

Weibo Corp

Weibo (WB US, BUY, TP US$26.9) Earnings Review: Maintain BUY for Margin Improvement